Health

Pandemic preparedness: lessons from covid-19

October 14, 2021

Global

Vaccines, pandemic preparedness

October 14, 2021

Global
Elly Vaughan

Senior Manager, Global Health Policy and Insights at Economist Impact

Elly is Senior Manager, Global Health Policy and Insights, at Economist Impact. Alongside working on a variety of projects on non-communicable diseases, Elly has specific expertise in emergency preparedness and response, as Lead of the Global Health Security Index and having worked on a number of reviews for the European Centre for Disease Prevention and Control (ECDC) and Robert Koch Institute, including several peer-reviewed publications.

David Humphreys, Economist Impact's global practice leader for health policy, will co-chair the Pandemic preparedness: lessons from covid-19 session at this year's World Health Summit. In this article, he highlights the importance of research to tackle future health challenges, as well as examples of our latest pandemic-related work.

The covid-19 pandemic has exacerbated long-standing issues in health, such as critical system weaknesses and growing inequity in care. It has also caused new gaps and policy levers. Beyond minimising the short and long-term impact of covid-19, stakeholders must strive for improved and more inclusive approaches to health and wellbeing. We have curated our field-leading work on system preparedness, pandemic response and health policy implications. Through research, we can identify sustainable ways to tackle future health challenges as a global community. 

If you would like to know more about any aspect of our work, please reach out to him at

Our latest pandemic-related work
 
  • - Our covid-19 health-funding tracker, supported by the Wellcome Trust, synthesises global health-related funding efforts to increase accountability and further pledges. We track the flow of money from pledge to disbursement towards the development, production and equitable access to new covid-19 diagnostics, therapeutics and vaccines.
  • - Our modelling suggests that a 10% reduction in NCD mortality, through better access to healthcare, would have reduced COVID-19 fatality by 20% in LMICs.
  • - Do masks protect the general public from coronavirus? Will mutations make the virus more aggressive? Economist Impact, in partnership with Reckitt Benckiser, demystifies prominent questions about covid-19.
  • - This project, supported by Sanofi, explores different national responses to the crisis. We have identified the factors that enable governments to strengthen, coordinate and refine future responses.
  • - This index measures how prepared 195 countries are to tackle major infectious disease outbreaks. The report is based on a 140-question survey organised across six categories, 34 indicators and 85 sub-indicators.
  • - Covid-19 has shown the power of scientific innovation in the vaccine arena. The Economist Group’s vaccine ecosystem initiative explores the components required to build a more resilient, dynamic and flexible vaccine ecosystem for the future.
 

For more information about how we could support your organisation, please contact  - global health business development lead, .

 

 

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week